Preparation and In vivo Evaluation of Mucoadhesive Microspheres for Gastroretentive Delivery of Misoprostol

DOI:

https://doi.org/10.37285/ijpsn.2017.10.2.6

Authors

  • Bhikshapathi D.V. R. N.
  • Ranjith Kumar K

Abstract

The aim of the present investigation was to prepare and evaluate the Misoprostol mucoadhesive microspheres for gastroretentive drug delivery. Sodium alginate and sodium carboxy methyl cellulose were used as mucoadhesive polymers. Microsphere formulations were prepared using Ionotropic gelation technique. All the microspheres were characterized for particle size, scanning electron microscopy, FT-IR study, percentage yield, drug entrapment, stability studies and for in vitro release kinetics. Based on the results, the formulation M12 was selected as optimized formulation. In vitro drug release study of optimized formulation M12 showed 98.23% after 12 h in a controlled manner, which is essential for anti ulcer therapy. The marketed product shows the drug release of 95.23 within 1 h. The results of mucoadhesion study showed better retention of prepared microspheres (8) h in chic duodenal and jejunum regions of intestine. The results showed significant higher retention of mucoadhesive microspheres in upper GI tract. Pharmacokinetic study revealed that the bioavailability was found to be increased significantly when compared with marketed tablets. The drug release of Misoprostol optimized formulation M12 followed zero order, Higuchi and Korsmeyer-Peppas kinetics indicating diffusion controlled with non-Fickian (anomalous) transport thus it projected that delivered its active ingredient by coupled diffusion and erosion. Overall, the result indicated prolonged delivery with improved bioavailability of Misoprostol from mucoadhesive microspheres due to higher retention in the upper GI tract.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Misoprostol, Bioavaialbility, Sodium CMC, Korsmeyer peppas, Mucoadhesive microspheres.

Downloads

Published

2017-03-31

How to Cite

1.
D.V. R. N. B, K RK. Preparation and In vivo Evaluation of Mucoadhesive Microspheres for Gastroretentive Delivery of Misoprostol . Scopus Indexed [Internet]. 2017 Mar. 31 [cited 2024 May 17];10(2):3676-83. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/836

Issue

Vol. 10 No. 2 (2017): March-April 2017

Section

Research Articles
Crossref
Scopus
Google Scholar
Europe PMC

References

Ashok T., Harish Ch., Mukesh P., Arvind D and Chatterjee D P. (2015). Formulation and evaluation of floating microspheres of atenolol, Panacea. J Pharmacy and Pharma Scie 4: 654-679.
Banker GS and Anderson NR. (1987). In: Lachman L, Lieberman HA, Kanig J. The theory and practice of industrial pharmacy. 3rd edition Published by Verghese publishing house; 293-345.
Capan Y., Jiang G., Giovagnoli S and De Luca PP. (2003). Preparation and characterization of poly (D, L-lactide-co-glyclide) microspheres for controlled release of human growth hormone. AAPS Pharm Sci Tech 4: E28.
Caroter SJ. (1986). Tutorial pharmacy. Power flow and Compaction, CBS publishers and distributors, New Delhi, India; 1st edition.
Das M.K. (2008). Furosamide loaded alginate microspheres prepared by ionic cross linking technique; Morphology and release characteristics. Indian journal of pharmaceutical science 70: 77-84.
Gogel MC and Amin AF (1998). Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. J Control Release 51: 115-122.
Hazender S and Dortunc B. (2004). Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int J Pharm 269: 131-140.
Ikeda K., Murata K., Kobayashi M and Noda K. (1992). Enhancement of bioavailability of dopamine via nasal route in beagle dogs. Chem Pharm Bull (Tokyo) 40: 2155-2158.
Ikawa K., Shimantani T., Hayato S., Morikawa N., Tazuma S. (2007). Pharmacokinetic and pharmacodynamics properties of Lafutidine after postprandial oral administration in healthy subjects: comparison with famotidine. Biol Pharm Bull 30(5): 1003-6.
Ilium L., Farraj NF., Critchley H and Davis SS. (1988). Nasal administration of gentamicin using a novel microsphere delivery system. Int J Pharm 46: 261-265.
Jain R. A. (2000). The manufacturing techniques of various drug loaded biodegradable poly (lactide-coglycolide) (PLGA) devices. Biomaterials 21: 2475-2490
Najm WI. (2011). Peptic ulcer disease. Primary care 38: 383-94.
Nagai T., Nishimoto Y., Nambu N., Suzuki Y and Sekine K. (1984). Powder dosage form of insulin for nasal administration. J Control Release 1: 15-22.
Rockvill. (1980). The United States Pharmacopoeia XX/ National Formulary XV. 15th edition. US Pharmacopoeial Convention, 958-990.
Rajput GC., Majumdar FD., Patel JK., Patel KN.,Thakor RS., Patel BP and Rajgor NB. (2010). Stomach Specific Mucoadhesive Tablets as Controlled Drug Delivery System-A Review Work. Int. J. Pharma.
Schaefer MJ and Singh J. (2000). Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres. AAPS Pharm Sci Tech 1: E32.
Sunil R., Dhaneshwar and Vidhya K. Bhusari. (2010). Validated HPLC Method for Simultaneous Quantitation of Diclofenac Sodium and Misoprostol in Bulk Drug and Formulation, Der Chemica Sinica 1(2): 110-118
Trivedi Parul (2008). Preparation and characterization of aceclofenac microspheres. Asian journal of pharmaceutics: 110-115.
Ugwoke MI., Agu RU., Verbeke N and Kinget R. (2005). Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Adv Drug Deliv Rev 57: 1640-65.
Sinha V. R and Trehan A., (2003). Biodegradable microspheres for protein delivery. Journal of Controlled Release 90: 261-280.
Woo BH., Jiang G and De Luca PP. (2001). Preparation and characterization of the composite PLGA and poly (acryloyl hydroxymethyl starch) microsphere system for protein delivery. Pharm Res 18: 1600-1606.